A practical, patient-centered guide to safely tapering benzodiazepines, balancing long-term risks, withdrawal challenges, and strategies that improve success.

A parent sits across from you and asks, "Why can't my child just take the same anxiety medicine that helps me?” Sounds reasonable, but the evidence tells a very different story.

Most patients with alcohol withdrawal can be safely managed outside the hospital. Dr. Holt outlines how to assess risk, choose between gabapentin and benzodiazepines, implement his “4-3-2-1” outpatient taper, and navigate real-world barriers such as comorbidities, unstable housing, and patient preference.

Dr. Gunderson provides expert guidance on recognizing and managing delirium tremens, challenging conventional wisdom about withdrawal timelines and offering practical approaches to risk stratification. He details his treatment approach for patients at high risk of developing withdrawal complications and discusses the differential diagnosis of delirium in hospitalized patients with alcohol use disorder.

Sleep disorders affect nearly half of adults over 65, impairing quality of life and increasing risks of cognitive decline, mood disorders, falls, metabolic syndrome, heart disease, stroke, and cancer.

"The only thing that works for me is Xanax." "Can I get a 3-month script for Klonopin? My last doc didn't mind."
We’ve all heard versions of these.

Dr. Morehead discusses when to use them, how to taper them, and new research on withdrawal risks.